StonvexLoading…
StonvexStonvexStonvexCore line items from GTY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $57.84M | $221.73M | $161.18M | $105.59M |
Operating Income | $38.26M | $126.78M | $86.04M | $51.29M |
Net Income | $26.63M | $79.19M | $52.15M | $28.80M |
EPS (Diluted) | $0.43 | $1.35 | $0.89 | $0.49 |
Total Assets | $2.18B | $2.17B | $2.06B | $2.02B |
Total Liabilities | $1.09B | $1.10B | $1.04B | $1.03B |
Cash & Equivalents | $3.70M | $8.36M | $5.19M | $7.49M |
Free Cash Flow OCF − CapEx | $33.07M | $127.02M | $93.61M | $63.18M |
Shares Outstanding | 60.47M | 59.82M | 57.74M | 56.59M |